KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-cash Items (2016)

AbbVie (ABBV) has disclosed Non-cash Items for 4 consecutive years, with $576.0 million as the latest value for Q2 2016.

  • On a quarterly basis, Non-cash Items rose 2408.16% to $576.0 million in Q2 2016 year-over-year; TTM through Jun 2016 was $576.0 million, a 2408.16% increase, with the full-year FY2015 number at $674.0 million, up 2543.45% from a year prior.
  • Non-cash Items was $576.0 million for Q2 2016 at AbbVie, up from $19.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.0 billion in Q4 2014 to a low of $3.0 million in Q2 2013.
  • A 4-year average of $346.2 million and a median of $36.6 million in 2013 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: skyrocketed 30366.67% in 2014, then tumbled 74.17% in 2015.
  • AbbVie's Non-cash Items stood at $912.0 million in 2013, then rose by 14.47% to $1.0 billion in 2014, then tumbled by 35.44% to $674.0 million in 2015, then dropped by 14.54% to $576.0 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Non-cash Items are $576.0 million (Q2 2016), $19.1 million (Q1 2016), and $674.0 million (Q4 2015).